HLA-A*24:02-positive PBMCs from COVID-19 mRNA vaccine recipients were cultured with T cell activators (CD3/CD28/CD2) and IL-2 for 10 days to expand T cell populations (Supplementary Table S3). This evidence concerns the gene IL2 and COVID-19.